Harbin Medisan Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 494.83 million compared to CNY 461.95 million a year ago. Revenue was CNY 504.74 million compared to CNY 473.83 million a year ago.

Net income was CNY 20.51 million compared to CNY 586.29 million a year ago. Basic earnings per share from continuing operations was CNY 0.07 compared to CNY 1.89 a year ago. Diluted earnings per share from continuing operations was CNY 0.07 compared to CNY 1.89 a year ago.